The new 2019 Surgical Instruments Market Report features refreshed data and new forecasts through 2024. The report examines trends in ophthalmic surgeries, analyzes the competitive landscape dominated by 10 companies, and addresses different market dynamics and competitive imperatives of disposable and reusable instrument market segments.
The report offers a comprehensive analysis of the 2019 global market for surgical instruments—both reusable and disposable—and forecasts market performance over the next five years. Important trends, market drivers, and key factors for future success are discussed. The report offers an overview of ophthalmic surgeries and surgery volume worldwide, as well as an in-depth look at providers of cataract surgery, the most commonly performed ophthalmic surgery.
Our report is designed to provide depth and context to the reader’s understanding of market dynamics in the single-use and disposable instrument market. Our coverage includes:
Descriptions of single-use and disposable ophthalmic surgical products.
Profiles of companies in the single-use and disposable ophthalmic surgical products industry.
Information on the global incidence of cataracts and global statistics on cataract surgeries.
Current estimates and five-year forecasts for cataract surgery volume worldwide.
Discussion of refractive lens exchange procedures.
Information on ophthalmic surgery providers.
US ASCs and cataract surgery providers worldwide.
Review of global cataract and glaucoma and treatment methods.
Global overview of ophthalmologists.
2 licensing types are available for this report:
Both licenses include an electronic PDF. Printed copies may be purchased for an additional $250.
SINGLE USER LICENSE
Bill Freeman has more than 35 years of experience developing, manufacturing, and marketing cataract surgery products. He has held key executive positions at four firms that produce ophthalmic surgical devices.
Bill’s career in ophthalmology began in the 1970s. As president of Cavitron Surgical Systems, he worked with Dr. Charles Kelman in developing and marketing the world’s first phacoemulsifier system. While highly controversial in the 1970s, phacoemulsification gradually became the preferred cataract removal technique in the early 1980s. For many years, Cavitron led the cataract instrumentation market.
CooperVision purchased Cavitron in the early 1980s, and Bill joined the company as president of the surgical division. CooperVision expanded its product line to include a wide variety of cataract surgical products—IOLs, viscoelastic solutions, disposable devices, lasers, and custom packs—and became the market leader in many product categories.
In 1989, Alcon acquired CooperVision in an effort to build a strong presence in cataract surgical devices. Bill joined Alcon as general manager of the Irvine Technology Center, where a number of the company’s cataract devices, including the Legacy 20000 phacoemulsifier and a broad line of disposable items, were designed and manufactured.
Bill remained with Alcon until 1995. He then joined Mentor Ophthalmics as president of the ophthalmology division. At Mentor, he was responsible for the company’s ophthalmic products including IOLs, cautery devices, and surgical instruments.
After leaving Mentor in 1999, Bill joined Market Scope in 2000 and now serves as executive vice president focusing on ophthalmic surgical cataract, retinal and glaucoma devices.
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.